Table 2.
Obese PCOS (n=36) | Obese controls (n=17) | p-value | |
---|---|---|---|
Systolic BP, mmHg | 114± 7 | 113 ± 7 | 0.621 |
Diastolic BP, mmHg | 65 ± 7 | 66 ± 5 | 0.368 |
Non-dipper | 9 (25.0%) | 1 (5.9%) | 0.082 |
Pre-hypertensive | 6 (16.7%) | 2 (11.8%) | 0.299 |
Urine microalbumin:creatinine ratio, mcg/mg creatinine | 25.22 ± 47.82 | 28.80 ± 393.50 | 0.817 |
cIMT, mm | 0.49 ± 0.07 | 0.44 ± 0.06 | 0.038 |
Carotid distention, mm | 0.82 ± 0.19 | 0.87 ± 0.17 | 0.275 |
Beta stiffness index, U | 5.1 ± 1.3 | 4.4 ± 0.9 | 0.037 |
Carotid compliance, mm2/mmHg × 10−1 | 1.95 ± 0.47 | 2.13 ± 0.43 | 0.047 |
LV mass index, g/m2.7 | 31.94 ± 6.10 | 31.86 ± 13.83 | 0.977 |
Fractional shortening, % | 35.19 ± 6.56 | 33.01 ± 6.83 | 0.270 |
Global longitudinal strain, % | −17.48 ± 2.17 | −16.80 ± 3.22 | 0.370 |
Global circumferential strain, % | −22.58 ± 4.81 | −22.59 ± 3.54 | 0.994 |
Continuous variables are presented as mean ± standard deviation; categorical variables as frequency (percentage).
A p-value in bold font indicates a significant difference between groups.
PCOS, polycystic ovarian syndrome; BP, blood pressure; cIMT, carotid intima–media thickness; LV, left ventricular.